AQR Capital Management’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $324K | Sell |
45,081
-115,686
| -72% | -$831K | ﹤0.01% | 2834 |
|
|
2025
Q1 | $963K | Buy |
160,767
+133,174
| +483% | +$798K | ﹤0.01% | 2035 |
|
|
2024
Q4 | $215K | Buy |
27,593
+15,881
| +136% | +$124K | ﹤0.01% | 2646 |
|
|
2024
Q3 | $126K | Buy |
+11,712
| New | +$126K | ﹤0.01% | 2633 |
|
|
2023
Q3 | – | Sell |
-13,633
| Closed | -$161K | – | 2326 |
|
|
2023
Q2 | $161K | Sell |
13,633
-2,688
| -16% | -$31.8K | ﹤0.01% | 2105 |
|
|
2023
Q1 | $176K | Sell |
16,321
-7,228
| -31% | -$78K | ﹤0.01% | 2068 |
|
|
2022
Q4 | $272K | Buy |
+23,549
| New | +$272K | ﹤0.01% | 2003 |
|